202 related articles for article (PubMed ID: 34215896)
41. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
[TBL] [Abstract][Full Text] [Related]
42. Impact of Idiopathic Pulmonary Fibrosis on Longitudinal Health-care Utilization in a Community-Based Cohort of Patients.
Farrand E; Iribarren C; Vittinghoff E; Levine-Hall T; Ley B; Minowada G; Collard HR
Chest; 2021 Jan; 159(1):219-227. PubMed ID: 32717266
[TBL] [Abstract][Full Text] [Related]
43. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
[TBL] [Abstract][Full Text] [Related]
44. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
45. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
[TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
[TBL] [Abstract][Full Text] [Related]
47. A nationwide population-based study of incidence and mortality of lung cancer in idiopathic pulmonary fibrosis.
Song MJ; Kim SY; Park MS; Kang MJ; Lee SH; Park SC
Sci Rep; 2021 Jan; 11(1):2596. PubMed ID: 33510351
[TBL] [Abstract][Full Text] [Related]
48. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
49. Clusters of comorbidities in idiopathic pulmonary fibrosis.
Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
Respir Med; 2021; 185():106490. PubMed ID: 34130097
[TBL] [Abstract][Full Text] [Related]
50. Coronary artery disease and heart failure in patients with idiopathic pulmonary fibrosis.
Kato S; Kitamura H; Hayakawa K; Fukui K; Tabata E; Otoshi R; Iwasawa T; Utsunomiya D; Kimura K; Tamura K; Ogura T
Heart Vessels; 2021 Aug; 36(8):1151-1158. PubMed ID: 33486554
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
52. Morbidity and mortality reduction associated with polysomnography testing in idiopathic pulmonary fibrosis: a population-based cohort study.
Vozoris NT; Wilton AS; Austin PC; Kendzerska T; Ryan CM; Gershon AS
BMC Pulm Med; 2021 Jun; 21(1):185. PubMed ID: 34078346
[TBL] [Abstract][Full Text] [Related]
53. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.
Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW
Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338
[TBL] [Abstract][Full Text] [Related]
54. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous Pneumomediastinum as a Potential Predictor of Mortality in Patients with Idiopathic Pulmonary Fibrosis.
Colombi D; Ehlers-Tenenbaum S; Palmowski K; Heussel CP; Sverzellati N; Silva M; Eichinger M; Kreuter M
Respiration; 2016; 92(1):25-33. PubMed ID: 27348534
[TBL] [Abstract][Full Text] [Related]
56. Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study.
Gupta R; Morgan AD; George PM; Quint JK
Thorax; 2024 Jun; 79(7):624-631. PubMed ID: 38688708
[TBL] [Abstract][Full Text] [Related]
57. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.
Alqalyoobi S; Fernández Pérez ER; Oldham JM
BMC Pulm Med; 2020 Nov; 20(1):289. PubMed ID: 33160338
[TBL] [Abstract][Full Text] [Related]
58. Combined pulmonary fibrosis and emphysema: a retrospective analysis of clinical characteristics, treatment and prognosis.
Zhang L; Zhang C; Dong F; Song Q; Chi F; Liu L; Wang Y; Che C
BMC Pulm Med; 2016 Nov; 16(1):137. PubMed ID: 27809901
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients With Idiopathic Pulmonary Fibrosis.
Liu GY; Ventura IB; Achtar-Zadeh N; Elicker BM; Jones KD; Wolters PJ; Collard HR; Adegunsoye A; Strek ME; Ley B
Chest; 2019 Oct; 156(4):715-723. PubMed ID: 31181198
[TBL] [Abstract][Full Text] [Related]
60. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.
Yoshimura K; Kono M; Enomoto Y; Nishimoto K; Oyama Y; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Sumikawa H; Johkoh T; Colby TV; Sugimura H; Suda T
Respir Med; 2018 Apr; 137():167-175. PubMed ID: 29605201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
